Cyclerion Therapeutics Inc
Research Cyclerion Therapeutics Inc (CYCN) on Bullrun: market cap USD 14.53M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCYCN
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 14.53M
- Financial periodFY2025
- RevenueUSD 2.07M
- Revenue growth3.7%
- Net income-USD 3.53M
Valuation Snapshot
latest market cap is USD 14.53M.
About Cyclerion Therapeutics Inc
Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. The company is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease.
Frequently asked questions
What is Cyclerion Therapeutics Inc's market cap?
Cyclerion Therapeutics Inc's market capitalization is USD 14.53M.
What does Cyclerion Therapeutics Inc do?
Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery.